SMTL ID : 9axr.2 (2 other biounits)

Crystal Structure of HY18-5B1_Ch Fab in Complex with Fentanyl

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 7V7: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide(Non-covalent)

7V7.1: 9 residues within 4Å: Chain A: Y.35, A.97, L.98, E.99, G.101 Chain B: Y.36, Y.55, Q.89, F.98 9 PLIP interactions: 4 interactions with chain B, 5 interactions with chain A Hydrophobic interactions: B:Y.36, B:F.98, A:Y.35, A:Y.35, A:A.97, A:E.99 Hydrogen bonds: B:Q.89 pi-Cation interactions: B:Y.91 Salt bridges: A:E.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rodarte, J. et al., Structure-Based Engineering of Monoclonal Antibodies for Improved Binding to Counteract the Effects of Fentanyl and Carfentanil. Acs Omega (2024)

Release Date

2024-10-02

Peptides

HY18-5B1_Ch Fab Heavy Chain: A
HY18-5B1_Ch Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

HY18-5B1_Ch Fab Heavy Chain

HY18-5B1_Ch Fab Light Chain

Related Entries With Identical Sequence